Literature DB >> 22112836

The Cu(II)-fluconazole complex revisited. Part I: Structural characteristics of the system.

Justyna Nagaj1, Radosław Starosta, Wojciech Szczepanik, Maciej Barys, Piotr Młynarz, Małgorzata Jeżowska-Bojczuk.   

Abstract

Protonation equilibria and Cu(II) binding processes by an antifungal agent fluconazole, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-yl-methyl)-1H-1,2,4-triazole-1-ethanol, were studied using the UV-Vis, EPR and NMR spectroscopic techniques. The protonation constant of fluconazole was determined from NMR titration and attributed to N4' nitrogen atoms using the DFT methods. The spectroscopic data suggest that at pH as low as 0.4 the first complex is formed, in which one or two Cu(II) ions are bound to one of the nitrogen atoms (N4') from triazole rings. Above pH 1.5 each Cu(II) ion is surrounded by two nitrogen atoms (also N4') from two different ligand molecules, forming primary monomeric complexes and above pH=5, both dimeric or oligomeric species occur, which is well registered by the EPR technique. The mixture of Cu(NO(3))(2) with fluconazole in a 1:1 molar ratio in a water (pH=4.5)/ethanol solution gave crystals of [Cu(2)(H(2)O){(C(6)H(3)-2,4-F(2))(CH(2)N(3)C(2)H(2))(2)C-OH}{(C(6)H(3)-2,4-F(2))(CH(2)N(3)C(2)H(2))(2)C-O}(NO(3))](NO(3))(2)·9(H(2)O). This complex is the first example of a cupric 3D polymeric structure with a fluconazole ligand coordinated via both N2' and N4' atoms from the same triazole rings. At higher pH values, we obtained a binuclear complex [Cu(2)(L)(2)(H(2)O)(2)(NO(3))(2)], in which the copper(II) atoms were bridged by the oxygen atoms of the deprotonated OH group of fluconazole. The hypothetical oxidative properties of this system were also examined, however it failed to generate either reactive oxygen species or DNA scission products.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22112836     DOI: 10.1016/j.jinorgbio.2011.09.014

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  Copper potentiates azole antifungal activity in a way that does not involve complex formation.

Authors:  Elizabeth W Hunsaker; Katherine J Franz
Journal:  Dalton Trans       Date:  2019-07-02       Impact factor: 4.390

2.  Copper Acts Synergistically With Fluconazole in Candida glabrata by Compromising Drug Efflux, Sterol Metabolism, and Zinc Homeostasis.

Authors:  Ana Gaspar-Cordeiro; Catarina Amaral; Vânia Pobre; Wilson Antunes; Ana Petronilho; Paulo Paixão; António P Matos; Catarina Pimentel
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

3.  Activity of fluconazole and its Cu(II) complex towards Candida species.

Authors:  Adam Ząbek; Justyna Nagaj; Agnieszka Grabowiecka; Ewa Dworniczek; Urszula Nawrot; Piotr Młynarz; Małgorzata Jeżowska-Bojczuk
Journal:  Med Chem Res       Date:  2014-10-09       Impact factor: 1.965

4.  Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro.

Authors:  Congyue Annie Peng; Andrea A E Gaertner; Sarah Ana Henriquez; Diana Fang; Rodney J Colon-Reyes; Julia L Brumaghim; Lukasz Kozubowski
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

5.  Copper(II) and Zinc(II) Complexes with the Clinically Used Fluconazole: Comparison of Antifungal Activity and Therapeutic Potential.

Authors:  Nevena Lj Stevanović; Ivana Aleksic; Jakob Kljun; Sanja Skaro Bogojevic; Aleksandar Veselinovic; Jasmina Nikodinovic-Runic; Iztok Turel; Miloš I Djuran; Biljana Đ Glišić
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.